Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phas... by Yardley, Denise A., Reeves, James, Dees, E. Claire, Osborne, Cynthia, Paul, Devchand, Ademuyiwa, Foluso, Soliman, Hatem, Guthrie, Troy, Andersen, Jay, Krekow, Lea, Choksi, Janak, Daniel, Brooke, Danso, Michael, Favret, Anne, Oommen, Sanjay, Brufsky, Adam, Bromund, Jane L., Lin, Yong, Ibrahim, Ayman B., Richards, Paul D.

Get full text

Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial by Socinski, Mark A., Raju, Robert N., Neubauer, Marcus, Smith, David A., Richards, Donald A., Savin, Michael, Ruxer, Robert L., Reynolds, Craig H., Zhan, Feng, Bromund, Jane L., Chen, Ruqin, Obasaju, Coleman

Get full text

Phase 1/2 Dose Escalating Study of Twice-Monthly Pemetrexed and Gemcitabine in Patients with Advanced Cancer and Non-small Cell Lung Cancer by Dudek, Arkadiusz Z., Larson, Timothy, McCleod, Michael J., Schneider, Daniel J., Dowell, Jonathan E., Banerjee, Tarit K., Pandya, Kishan J., Bromund, Jane L., Chen, Ruqin, Monberg, Matthew J., Obasaju, Coleman K.

Get full text

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-sma... by Socinski, Mark A., Raju, Robert N., Stinchcombe, Thomas, Kocs, Darren M., Couch, Linda S., Barrera, David, Rousey, Steven R., Choksi, Janak K., Jotte, Robert, Patt, Debra A., Periman, Phillip O., Schlossberg, Howard R., Weissman, Charles H., Wang, Yunfei, Asmar, Lina, Pritchard, Sharon, Bromund, Jane, Peng, Guangbin, Treat, Joseph, Obasaju, Coleman K.

Get full text

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer by Brufsky, Adam, Hoelzer, Karen, Beck, Thaddeus, Whorf, Robert, Keaton, Mark, Nadella, Padma, Krill-Jackson, Elisa, Kroener, Joan, Middleman, Edward, Frontiera, Michael, Paul, Devchand, Panella, Timothy, Bromund, Jane, Zhao, Luping, Orlando, Mauro, Tai, Fritz, Marciniak, Martin D, Obasaju, Coleman, Hainsworth, John

Get full text

Ramucirumab Plus Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phas... by Yardley, Denise A., MD, Reeves, James, MD, Dees, E. Claire, MD, Osborne, Cynthia, MD, Paul, Devchand, PhD, Ademuyiwa, Foluso, MD, Soliman, Hatem, MD, Guthrie, Troy, MD, Andersen, Jay, MD, Krekow, Lea, MD, Choksi, Janak, MD, Daniel, Brooke, MD, Danso, Michael, MD, Favret, Anne, MD, Oommen, Sanjay, MD, Brufsky, Adam, MD, Bromund, Jane L., MSN, Lin, Yong, PhD, Ibrahim, Ayman B., MD, Richards, Paul D., MD

Get full text

Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer by Borson, Rachel, Harker, Graydon, Reeves, James, Beck, Thaddeus, Hager, Steven, Horvath, William, Jones, Michael, Tillinghast, Guy, Arrowsmith, Edward, Harrer, Grant, Kudrik, Fred J, Malamud, Stephen C, Bromund, Jane, Zeigler, Haoyue, Tai, Datchen Fritz, Kornberg, Lori J, Obasaju, Coleman, Orlando, Mauro, Yardley, Denise A

Get full text

P1-229: The impact of shortened vitamin supplementation lead-in time before pemetrexed (P) in patients with relapsed small-cell lung cancer (SCLC) by Socinski, Mark A., Raju, Robert N., Richards, Donald A., Coke, Kelli, Reynolds, Craig H., Chen, Ruqin, Bromund, Jane L., Treat, Joseph, Obasaju, Coleman K.

Get full text

P2-293: Final results of a phase 1/2 study of biweekly pemetrexed and gemcitabine in patients with advanced NSCLC by Dudek, Arkadiusz, Larson, Tim, McCleod, Michael, Schneider, Daniel J., Dowell, Jonathan E., Banerjee, Tarit K., Pandya, Kishan J., Bromund, Jane, Kirsch, Kelly, Obasaju, Coleman K.

Get full text

P2-292: A randomized Phase 3 trial of gemcitabine with or without carboplatin in performance status 2 (PS2) patients with advanced (stage IIIB with pleural effusion or IV) non-smal... by Reynolds, Craig, Conkling, Paul, Richards, Donald A., Fitzgibbons, James F., Arseneau, James C., Boehm, Kristi A., Asmar, Lina, Bromund, Jane, Peng, Guangbin, Obasaju, Coleman K.

Get full text